Ito, E., Miyagawa, S., Takeda, M., Kawamura, A., Harada, A., Iseoka, H., . . . Sawa, Y. (2019). Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application. Sci Rep.
Chicago Style CitationIto, Emiko, et al. "Tumorigenicity Assay Essential for Facilitating Safety Studies of HiPSC-derived Cardiomyocytes for Clinical Application." Sci Rep 2019.
Cita MLAIto, Emiko, et al. "Tumorigenicity Assay Essential for Facilitating Safety Studies of HiPSC-derived Cardiomyocytes for Clinical Application." Sci Rep 2019.
Atenció: Aquestes cites poden no estar 100% correctes.